Sterility and Infection

  • Showan N. Nazhat
  • Anne M. Young
  • Jonathan Pratten


Biomaterials implanted into the body need to be sterile in order to avoid infections which can lead to illness and even mortality. Sterility can be defined as the absence of all living organisms, particularly microorganisms. Indeed, the presence of one bacterium would render a medical device non-sterile. Nearly one-third of implant related infections can be prevented by strictly following established infection control guidelines, but in a period of healthcare cost reductions this is increasingly difficult to sustain.


Ethylene Oxide Gingival Crevicular Fluid Chlorine Dioxide Fluoride Release Antimicrobial Coating 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Addy M and Martin MV. Systemic antimicrobials in the treatment of chronic periodontal diseases: a dilemma. Oral Dis, 2003, 9: 38–44.CrossRefGoogle Scholar
  2. 2.
    An YH and Friedman RJ. Concise review of mechanisms of bacterial adhesion to biomaterial surfaces. J Biomed Mater Res, 1998, 43: 338–348.CrossRefGoogle Scholar
  3. 3.
    Andersson-Wenckert IE, van Dijken JW, and Kieri C. Durability of extensive class II open-sandwich restorations with a resin-modified glass ionomer cement after 6 years. Am J Dentistry, 2004, 17(1): 43–50.Google Scholar
  4. 4.
    Bayston R. Medical problems due to biofilms: Clinical impact, aetiology, molecular pathogenesis, treatment and prevention, in Newman HN and Wilson M, eds. Dental Plaques Revisited: Oral Biofilms in Health and Disease, Bioline: Cardiff, UK, 1999.Google Scholar
  5. 5.
    Bayston R. Biofilms in medicine and disease: An overview, in Wimpenny J, Gilbert P, Walker J, Brading M, and Bayston R, eds. Biofilms: The Good, the Bad and the Ugly, Bioline: Cardiff, UK, 1999.Google Scholar
  6. 6.
    Beikler T, Prior K, Ehmke B, and Flemmig TF. Specific antibiotics in the treatment of periodontitis – a proposed strategy. J Periodontol, 2004, 75: 169–175.Google Scholar
  7. 7.
    Berbari EF, Hanssen AD, Duffy MC, Steckelberg JM, Ilstrup DM, Harmsen WS, and Osmon DR. Risk factors for prosthetic joint infection: case control study. Clin Infect Dis, 1998, 27: 1247–1254.CrossRefGoogle Scholar
  8. 8.
    Bernard L, Hoffmeyer P, Assal M, Vaudaux P, Schrenzel J, and Lew D. Trends in the treatment of orthopaedic prosthetic infections. J Antimicrob Chemother, 2004, 53: 127–129.CrossRefGoogle Scholar
  9. 9.
    Boxma H, Broekhuizen T, Patka P, and Oosting H. Randomised controlled trial of single dose antibiotic prophylaxis in surgical treatment of closed fractures: the Dutch Trauma Trial. Lancet, 1996, 347: 1133–1137.Google Scholar
  10. 10.
    Brisset L, Vernet-Garnier V, Carquin J, Burde A, Flament JB, and Choisy C. In vivo and in vitro analysis of the ability of urinary catheters to microbial colonization. Pathol Biol, 1996, 44: 397–404.Google Scholar
  11. 11.
    Buchholz HW and Englebrecht H. Depot effects of various antibiotics mixed with Palacos resins. Chirurg, 1970, 41: 511–515.Google Scholar
  12. 12.
    Burrows LL and Khoury AE. Infection of medical devices, in Wnek GE and Bowlin GL, eds. Encyclopedia of Biomaterials and Biomedical Engineering, Marcel Dekker Inc: New York, 2004.Google Scholar
  13. 13.
    Charnley J. Postoperative infection after total hip replacements with special reference to air contamination in the operating room. Clin Orthop, 1972, 87: 167–187.CrossRefGoogle Scholar
  14. 14.
    Ching DW, Gould IM, Rennie JA, and Gibson PH. Prevention of late haematogenous infection in major prosthetic joints. J Antimicrob Chemother, 1989, 23: 676–680.Google Scholar
  15. 15.
    Combe E. Dental Biomaterials, Kluwer Academic Publishers: Boston/London, 1999.Google Scholar
  16. 16.
    Darouiche RO. Antimicrobial approaches for preventing infections associated with surgical implants. Clin Infect Dis, 2003, 36: 1284–1289.Google Scholar
  17. 17.
    Donlan RM. Biofilms and device-associated infections. Emerging Infect Dis, 2001, 7: 277–281.CrossRefGoogle Scholar
  18. 18.
    Donlan RM and Costerton JW. Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev, 2002, 15: 167–193.Google Scholar
  19. 19.
    Furno F and Bayston R. Antimicrobial/antibiotic (infective resistance) materials, in Wnek GE and Bowlin GL, eds. Encyclopedia of Biomaterials and Biomedical Engineering, Marcel Dekker Inc: New York, 2004.Google Scholar
  20. 20.
    Garvin KL, Fitzgerald RH Jr, Salvati EA, Brause BD, Nercessian OA, Wallrichs SL, and Ilstrup DM. Reconstruction of the infected total hip or knee arthroplasty with gentamicin-impregnated Palacos bone cement. Instr Course Lect, 1993, 42: 293–302.Google Scholar
  21. 21.
    Gilbert P, Das J, and Foley I. Biofilm susceptibility to antimicrobials. Adv Dent Res, 1997, 11: 160–167.CrossRefGoogle Scholar
  22. 22.
    Götz F. Staphylococcus and biofilms. Mol Microbiol, 2002, 43: 1367–1378.CrossRefGoogle Scholar
  23. 23.
    Henderson B and Nair SP. Hard labour: bacterial infection of the skeleton. Trends Microbiol, 2003, 11: 570–577.CrossRefGoogle Scholar
  24. 24.
    Hendriks JGE, van Horn JR, van der Mei HC, and Busscher HJ. Backgrounds of antibiotic loaded bone cement and prosthesis related infection. Biomaterials, 2004, 25: 545–556.CrossRefGoogle Scholar
  25. 25.
    Hunter G and Dandy D. The natural history of the patient with a total hip replacement. J Bone Joint Surg Br, 1977, 59: 293–297.Google Scholar
  26. 26.
    Imazato S, Russel RR, and McCabe JF. Antibacterial activity of MDPB polymer incorporated in dental resin. J Dent, 1995, 23: 177–181.CrossRefGoogle Scholar
  27. 27.
    Mah TF and O’Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol, 2001, 9: 34–39.CrossRefGoogle Scholar
  28. 28.
    Matharu S, Spratt DA, Pratten J, Ng YL, Mordan N, Wilson M, and Gulabivala K. A new in vitro model for the study of microbial microleakage around dental restorations: A preliminary qualitative evaluation. Int Endod J, 2001, 34: 547–553.Google Scholar
  29. 29.
    Modak SM and Fox CL. Binding of silver sulfadiazine to cellular components of Pseudomonas-aeruginosa. Biochem Pharmacol, 1973, 22: 2391–2404.CrossRefGoogle Scholar
  30. 30.
    Nicholson JW. Chemistry of glass-ionomer cements: a review. Biomaterials, 1998, 19: 485–494.CrossRefGoogle Scholar
  31. 31.
    O’Brien WJ. Dental Materials and Their Selection, 2nd edn, Quintessence: Illinois, 1997, pp. 97–113.Google Scholar
  32. 32.
    Palmer G, Jones FH, Billington RW, and Pearson GJ. Chlorhexidine release from an experimental glass ionomer cement. Biomaterials, 2004, 25: 5423–5431.CrossRefGoogle Scholar
  33. 33.
    Potera C. Microbiology – forging a link between biofilms and disease. Science, 1999, 283: 1837–1838.CrossRefGoogle Scholar
  34. 34.
    Riedl CR, Plas E, Hubner WA, Zimmerl H, Ulrich W, and Pfluger H. Bacterial colonization of ureteral stents. Eur Urol, 1999, 36: 53–59.CrossRefGoogle Scholar
  35. 35.
    Salvati EA, Gonzalez Della Valle A, Masri BA, and Duncan CP. The infected total hip arthroplasty. Instr Course Lect, 2003, 42: 223–345.Google Scholar
  36. 36.
    Sanders BJ, Gregory RL, Moore K, and Avery DR. Antibacterial and physical properties of resin modified glass-ionomers combined with chlorhexidine. J Oral Rehabil, 2002, 29: 553–558.CrossRefGoogle Scholar
  37. 37.
    Schierholz JM and Beuth J. Implant infections: a haven for opportunistic bacteria. J Hosp Infect, 2001, 49: 87–93.CrossRefGoogle Scholar
  38. 38.
    Splieth C, Bernhardt O, Heinrich A, Bernhardt H, and Meyer G. Anaerobic microflora under class I and class II composite and amalgam restorations. Quintessence Int, 2003, 34: 497–503.Google Scholar
  39. 39.
    Stickler DJ. Biomaterials to prevent nosocomial infections: is silver the gold standard? Curr Opin Infect Dis, 2000, 13: 389–393.Google Scholar
  40. 40.
    Su SH, Conroy S, Lin TL, Sheu MS, and Loh IH. Surface coatings, in Wnek GE and Bowlin GL, eds. Encyclopedia of Biomaterials and Biomedical Engineering, Marcel Dekker Inc: New York, 2004.Google Scholar
  41. 41.
    Wang CJ, Huang TW, aWang JW, and aChen HS. The often poor clinical outcome of infected total knee arthroplasty. J Arthroplasty, 2002, 17: 608–614.Google Scholar
  42. 42.
    Wilson M. Bacterial biofilms and human disease. Sci Prog, 2001, 84: 235–254.CrossRefGoogle Scholar
  43. 43.
    Xu X and Burgess JO. Compressive strength, fluoride release and recharge of fluoride-releasing materials. Biomaterials, 2003, 24: 2451–2461.CrossRefGoogle Scholar
  44. 44.
    Yoshida K, Tanagawa M, and aAtsuta M. Characterization and inhibitory effect of antibacterial dental resin composites incorporating silver-supported materials. J Biomed Mater Res, 1999, 47: 516–522.CrossRefGoogle Scholar
  45. 45.
    Young AM, Leung D, Ho S, Rafeeka SA, Pratten J, and Spratt DA, Gulabivala K. Chemical, Mechanical and Biological Studies of New Antibacterial Aesthetic Restorative Materials. Medical Polymers, Rapra Technology Ltd: Shawbury, 2003.Google Scholar
  46. 46.
    Young AM, Leung D, Ho S, Sheung Y, Pratten J, and Spratt DA. New Injectable Antibacterial Polymers for Bone and Tooth Repair. Medical Polymers, Rapra Technology Ltd: Shawbury, 2004.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Showan N. Nazhat
    • 1
  • Anne M. Young
    • 2
  • Jonathan Pratten
    • 3
  1. 1.Department of Mining and Materials EngineeringMcGill UniversityMontrealUK
  2. 2.Biomaterials and Tissue Engineering DivisionUCL Eastman Dental Institute, University College LondonLondonUK
  3. 3.Division of Microbial Diseases, Eastman Dental InstituteUniversity College LondonLondonUK

Personalised recommendations